Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.91
+0.05 (0.73%)
At close: Dec 5, 2025, 4:00 PM EST
6.89
-0.02 (-0.29%)
After-hours: Dec 5, 2025, 7:59 PM EST
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,118,331
Profits / Employee
$358,976
Market Cap
1.12B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVAX News
- 4 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 5 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 5 days ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 17 days ago - Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 23 days ago - Shah Capital pushes for Novavax sale, warns of proxy fight - Reuters
- 24 days ago - Novavax to Participate in Jefferies London Healthcare Conference - PRNewsWire
- 4 weeks ago - Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights - PRNewsWire